Litcius/Paper detail

NFYB potentiates STK33 activation to promote cisplatin resistance in diffuse large B-cell lymphoma

Lili Feng, Xiaofang Xu, Keke Zhao

2021Leukemia Research17 citationsDOI

Topics & Concepts

Cancer researchCisplatinLymphomaDiffuse large B-cell lymphomaMedicineInternal medicineChemotherapyLymphoma Diagnosis and TreatmentHedgehog Signaling Pathway StudiesWnt/β-catenin signaling in development and cancer
NFYB potentiates STK33 activation to promote cisplatin resistance in diffuse large B-cell lymphoma | Litcius